Research Interests: My lab has an active research program in clinical neuroscience of addiction. My approach to clinical science involves the integration of experimental psychopathology, behavioral genetics, and pharmacology. More recently, my laboratory began using neuroimaging methods to complement our research program.
A full list of my publications and presentations can be seen in my CV here.
In the news: Dr. Lara Ray receives the ACNP Eva King – Killam Research Award! The American College of Neuropsychopharmacology (ACNP) has named Lara Ray, Ph.D. as one of two winners of the Eva King – Killam Research Award. The Eva King – Killam award, presented at the 56th Annual Meeting of the ACNP in Palm Springs, California, is presented on the basis of outstanding translational research contributions to neuropsychopharmacology.
Below are some recent representative publications:
Ray, L.A., Bujarski, S.E., Shoptaw, S., Roche, D.J.O., Heinzerling, K., & Miotto, K. (2017). Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: A randomized, placebo-controlled, human laboratory trial. Neuropsychopharmacology, 42, 1776-1788.
Ray, L.A., Green, R., Roche, D.J.O., Bujarski, S.E., Hartwell, E. E., Lim, A., Rohrbaugh, T., Ghahremani, D., Hutchison, K.E., & Miotto, K. (2018). Pharmacogenetic effects of naltrexone in individuals of East Asian descent: Human laboratory findings from a randomized trial. Alcoholism: Clinical and Experimental Research, 42(3), 613-623.